Fine mapping of the amyloid β-protein binding site on myelin basic protein

Biochemistry

Volumn 52, Issue 15, 2013, Pages 2565-2573

  Kotarba, Annmarie E ^a   Aucoin, Darryl ^a   Hoos, Michael D ^a   Smith, Steven O ^a   Van Nostrand, William E ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE-SCANNING MUTAGENESIS; ALZHEIMER'S DISEASE; C-TERMINAL REGIONS; DELETION MAPPING; MYELIN BASIC PROTEIN; POTENT INHIBITOR; PROTEIN-BINDING SITES; STRUCTURAL INSIGHTS;

AMINO ACIDS; BINDING SITES; GLYCOPROTEINS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

PROTEINS;

ALANINE; AMYLOID BETA PROTEIN; MYELIN BASIC PROTEIN; THIOFLAVINE;

ALZHEIMER DISEASE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CLINICAL FEATURE; FLUORESCENCE MICROSCOPY; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSMISSION ELECTRON MICROSCOPY;

ALANINE; AMYLOID BETA-PEPTIDES; BINDING SITES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; MUTAGENESIS, SITE-DIRECTED; MYELIN BASIC PROTEIN; PEPTIDE FRAGMENTS; THIAZOLES;

EID: 84876275084     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi4001936     Document Type: Article

References (68)

1. Selkoe, D. J. (2001) Alzheimer's disease: Genes, proteins, and therapy Physiol. Rev. 81, 741-766
2. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297, 353-356
3. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4269
4. De Felice, F. G., Viera, M. N. N., Saraiva, L. M., Figueroa-Villar, J. D., Garci-Abreu, J., Liu, R., Chang, L., Klein, W. L., and Ferreira, S. T. (2004) Targeting the neurotoxic species in Alzheimer's disease: Inhibitors of Aβ oligomerization FASEB J. 18, 1366-1372
5. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325, 733-736
6. Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., and Gajdusek, D. C. (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease Science 235, 877-880
7. Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., and Neve, R. L. (1987) Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus Science 235, 880-884
8. Robakis, N. K., Ramakrishna, N., Wolfe, G., and Wisniewski, H. M. (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides Proc. Natl. Acad. Sci. U.S.A. 84, 4190-4194
9. Vassar, R., Bennett, B. D., Babu-Khan, S., Khan, S., Mendiaz, E., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J.-C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999) β-Secretase cleavage of the Alzheimer's precursor protein by the transmembrane aspartic protease BACE Science 286, 735-741
10. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberberg, I., Power, M., Tanh, H., Tatsuno, G., Ting, J., Schenk, D., Suomensaari, S. M., Wang, S., Walker, D., and John, V. 1999, Purification and cloning of amyloid precursor protein β-secretase from human brain Nature 402, 537-540
11. Beck, J. P., Bienkowski, M. J., Sinha, S., and Heinrikson, R. L. (2003) Human β-secretase (BACE) and BACE inhibitors J. Med. Chem. 46, 4625-4630
12. De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., and Van Leuven, F. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein Nature 391, 387-390
13. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., and Selkoe, D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity Nature 398, 513-517
14. Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H., and Haass, C. (2003) Reconstitution of γ-secretase activity Nat. Cell Biol. 5, 486-488
15. Jellinger, K. A. (2002) Alzheimer's disease and cerebrovascular pathology: An update J. Neural Transm. 109, 813-836
16. Rensink, A. A., de Waal, R. M., Kremer, B., and Verbeek, M. M. (2003) Pathogenesis of cerebral amyloid angiopathy Brain Res. Brain Res. Rev. 43, 207-223
17. Attems, J., Jellinger, K., Thal, D. R., and Van Nostrand, W. (2011) Sporadic cerebral amyloid angiopathy Neuropathol. Appl. Neurobiol. 37, 75-93
18. Findeis, M. A. (2007) The role of amyloid β peptide 42 in Alzheimer's disease Pharmacol. Ther. 116, 266-286
19. Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T., Luyendijk, W., and Frangione, B. (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type Science 248, 1124-1126
20. Van Broeckhoven, C., Haan, J., Bakker, E., Hardy, J. A., Van Hul, W., Wehnert, A., Vegter-Van der Vlis, M., and Roos, R. A. (1990) Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch) Science 248, 1120-1122
21. Grabowski, T. J., Cho, H. S., Vonsattel, J. P., Rebeck, G. W., and Greenberg, S. M. (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy Ann. Neurol. 49, 697-705
22. Davis, J. and Van Nostrand, W. E. (1996) Enhanced pathologic properties of Dutch-type mutant amyloid β-protein Proc. Natl. Acad. Sci. U.S.A. 93, 2996-3000
23. Verbeek, M. M., de Waal, R. M., Schipper, J. J., and Van Nostrand, W. E. (1997) Rapid degeneration of cultured human brain pericytes by amyloid β protein J. Neurochem. 68, 1135-1141
24. Miravalle, L., Tokuda, T., Chiarle, R., Giaccone, G., Bugiani, O., Tagliavini, F., Frangione, B., and Ghiso, J. (2000) Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells J. Biol. Chem. 275, 27110-27116
25. Melchor, J. P., McVoy, L., and Van Nostrand, W. E. (2000) Charge alterations of E22 enhance the pathogenic properties of the amyloid β-protein J. Neurochem. 74, 2209-2212
26. Van Nostrand, W. E., Melchor, J. P., Cho, H. S., Greenberg, S. M., and Rebeck, G. W. (2001) Pathogenic effects of D23N Iowa mutant amyloid β-protein J. Biol. Chem. 276, 32860-32866
27. Stine, W. B., Jr., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis J. Biol. Chem. 278, 11612-11622
28. Paravastua, A. K., Leapman, R. D., Yau, W. M., and Tycko, R. (2008) Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils Proc. Natl. Acad. Sci. U.S.A. 105, 18349-18354
29. Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., and Smith, S. O. (2010) Structural conversion of neurotoxic amyloid-β(1-42) oligomers to fibrils Nat. Struct. Mol. Biol. 17, 561-567
30. Ono, K., Condron, M. M., and Teplow, D. B. (2009) Structure-neurotoxicity relationships of amyloid β-protein oligomers Proc. Natl. Acad. Sci. U.S.A. 106, 14745-14750
31. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416, 535-539
32. Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., Regan, C. M., Walsh, D. M., Sabatini, B. L., and Selkoe, D. J. (2008) Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14, 837-842
33. Glabe, C. G. (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease Neurobiol. Aging 27, 570-575
34. Urbanc, B., Cruz, J., Le, R., Sanders, J., Hsiao Ashe, K., Duff, K., Stanley, H. E., Irizarry, M. C., and Hyman, B. T. (2002) Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 99, 13990-13995
35. Van Nostrand, W. E., Melchor, J., and Ruffini, L. (1998) Pathogenic cell surface amyloid β-protein fibril assembly in cultured human cerebrovascular smooth muscle cells J. Neurochem. 70, 216-223
36. Rogers, J., Cooper, N. R., Webster, S., Schulz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., and Lieberburg, I. (1992) Complement activation by β-amyloid in Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 89, 10016-10020
37. Tacnet-Delorme, P., Chevallier, S., and Arlaud, G. J. (2001) β-Amyloid fibrils activate the C1 complex of complement under physiological conditions: Evidence for a binding site for Aβ on the C1q globular regions J. Immunol. 167, 6374-6381
38. Rozemuller, A. J., van Gool, W. A., and Eikelenboom, P. (2005) The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: Therapeutic implications Curr. Drug Targets: CNS Neurol. Disord. 4, 223-233
39. Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., and Landreth, G. E. (2009) CD14 and toll-like receptors 2 and are required for fibrillar Aβ-stimulated microglial activation J. Neurosci. 29, 11982-11992
40. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schemchel, D., Saunders, A. M., Goldgaber, D., and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 90, 8098-8102
41. LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., and Frail, D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid J. Biol. Chem. 269, 23403-23406
42. Wisniewski, T., Castano, E. M., Golabek, A., Vogel, T., and Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein-E in vitro Am. J. Pathol. 145, 1030-1035
43. Manelli, A. M., Stine, W. B., van Eldik, L. J., and LaDu, M. J. (2004) ApoE and Aβ42 interactions: Effects of isoform and conformation on structure and function J. Mol. Neurosci. 23, 235-246
44. Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., Ghetti, B., and Paul, S. M. (1999) Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 96, 15233-15238
45. Costa, D. A., Nilsson, L. N., Bales, K. R., Paul, S. M., and Potter, H. (2004) Apolipoprotein E is required for the formation of filamentous amyloid, but not for amorphous Aβ deposition, in an AβPP/PS double transgenic mouse model of Alzheimer's disease J. Alzheimer's Dis. 6, 509-514
46. Matsubara, E., Fragnione, B., and Ghiso, J. (1995) Characterization of Apolipoprotein J-Alzheimers Aβ interaction J. Biol. Chem. 270, 7563-7567
47. DeMattos, R. B., O'dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A., Bales, K. R., Paul, S. M., Aronow, B. J., and Holtzman, D. M. (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 99, 10843-10848
48. Lefterov, I., Fitz, N. F., Cronican, A. A., Fogg, A., Lefterov, P., Kodali, R., Wetzel, R., and Koldamova, R. (2010) Apolipoprotein A-1 deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1dE9 mice J. Biol. Chem. 285, 36945-36957
49. Lewis, T. L., Cao, D., Lu, H., Mans, R. A., Su, Y. R., Jungbauer, L., Linton, M. F., Fazio, S., LaDu, M. J., and Li, L. (2010) Overexpression of human apolipoprotein A-I preserves cognition and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer's disease J. Biol. Chem. 285, 36958-36968
50. Aksenova, M. V., Aksenova, M. Y., Butterfield, D. A., and Carney, J. M. (1996) α-1-Antichymotrypsin interaction with Aβ(1-40) inhibits fibril formation but does not affect the peptide toxicity Neurosci. Lett. 211, 45-48
51. Potter, H., Wefes, I. M., and Nilsson, L. N. (2001) The inflammation-induced pathological chaperones ACT and apoE are necessary catalysts of Alzheimer amyloid formation Neurobiol. Aging 22, 923-930
52. Schwarzman, A. L., Tsiper, M., Wente, H., Wang, A., Vitek, M. P., Vasiliev, V., and Goldgaber, D. (2004) Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants Amyloid 11, 1-9
53. Buxbaum, J. N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A. R., and Bartfai, T. (2008) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity Proc. Natl. Acad. Sci. U.S.A. 105, 2681-2686
54. Kakio, A., Nishimoto, S. I., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid J. Biol. Chem. 276, 24985-24990
55. Yamamoto, N., Hirabayashi, Y., Amari, M., Yamaguchi, H., Romanov, G., Van Nostrand, W. E., and Yanagisawa, K. (2005) Assembly of hereditary amyloid β-protein variants in the presence of favorable gangliosides FEBS Lett. 579, 2185-2190
56. Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2007) Inhibition of familial cerebral amyloid angiopathy mutant amyloid β-protein fibril assembly by myelin basic protein J. Biol. Chem. 282, 9952-9961
57. Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2009) Myelin basic protein binds to and inhibits the fibrillar assembly of Aβ42 in vitro Biochemistry 48, 4720-4727
58. Liao, M. C., Hoos, M. D., Aucoin, D., Ahmed, M., Davis, J., Smith, S. O., and Van Nostrand, W. E. (2010) Amino terminal domain of myelin basic protein inhibits amyloid β-protein fibril assembly J. Biol. Chem. 285, 35590-35598
59. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs J. Biol. Chem. 267, 546-554
60. Hou, L. M., Shao, H., Zhang, Y., Li, H., Menon, N. K., Neuhaus, E. B., Brewer, J. M., Byeon, I. J. L., Ray, D. G., Vitek, M. P., Iwashita, T., Makula, R. A., Przybyla, A. B., and Zagorski, M. G. (2004) Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the met35 oxidation state affects the mechanism of amyloid formation J. Am. Chem. Soc. 126, 1992-2005
61. Fawzi, N. L., Ying, J., Ghirlando, R., Torchia, D. A., and Clore, G. M. (2011) Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR Nature 480, 268-272
62. Ladiwala, A. R. A., Lin, J. C., Bale, S. S., Marcelino-Cruz, A. M., Bhattacharya, M., Dordick, J. S., and Tessier, P. M. (2010) Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Aβ into off-pathway conformers J. Biol. Chem. 285, 24228-24237
63. Ono, K., Li, L., Takamura, Y., Yoshiike, Y., Zhu, L., Han, F., Mao, X., Ikeda, T., Takasaki, J., Nishijo, H., Takashima, A., Teplow, D., Zagorski, M., and Yamada, M. (2012) Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site specific binding J. Biol. Chem. 287, 14631-14643
64. Liu, C. C., Kanekiyo, T., Xu, H., and Bu, G. (2013) Apolipoprotein E and Alzheimer's disease: Risk, mechanisms and therapy Nat. Rev. Neurol. 9, 106-118
65. Behrouz, N., Defossez, A., Delacourte, A., and Mazzuca, M. (1991) The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease J. Gerontol. 46, B209-B212
66. Wisniewski, H. M., Bancher, C., Barcikowska, M., Wen, G. Y., and Currie, J. (1989) Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease Acta Neuropathol. 78, 337-347
67. Barker, R. L., Loegering, D. A., Ten, R. M., Hamann, K. J., Pease, L. R., and Gleich, G. J. (1989) Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases J. Immunol. 143, 952-959
68. Mastrangelo, I. A., Ahmed, M., Sato, T., Liu, W., Wang, C., Hough, P., and Smith, S. O. (2006) High-resolution atomic force microscopy of soluble Aβ42 oligomers J. Mol. Biol. 358, 106-119